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The aim of the present study was to evaluate the eﬀects of N-acetylcysteine (NAC) and L-carnitine (LCAR) supplementations on
polymorphonuclear leukocytes myeloperoxidase (MPO) and Cu/Zn-superoxide dismutase (Cu/Zn-SOD) and plasma malondialde-
hyde (MDA) in acetic acid (AA)-induced ulcerative colitis model. The mean polymorphonuclear leukocyte MPO and Cu/Zn-SOD
activity was signiﬁcantly higher in the colitis group than in the control group. Both NAC and LCAR pretreatment markedly de-
creased MPO and Cu/Zn-SOD activity compared to colitis group. AA administration signiﬁcantly increased the levels of plasma
MDA in comparison with controls. However, NAC and LCAR administration to the AA-treated rats signiﬁcantly reduced the MDA
levels compared to colitis group. In conclusion NAC and LCAR could be beneﬁcial agents in restoring the circulating proinﬂamma-
tory mediators.
INTRODUCTION
Ulcerative colitis is a chronic recurrent inﬂammatory
bowel disease (IBD) of unknown origin. Oxidative stress
is believed to be a key factor in the pathogenesis and per-
petuation of the mucosal damage in IBD. In addition,
neutrophils and monocytes in patients with active IBD
have been shown to produce higher concentrations of
oxygen-derived free radicals than those in controls. Ex-
cessive production of reactive oxygen species (ROS) could
also be demonstrated for circulating phagocytic cells in
patients with IBD [1] and was shown to be involved in
several experimental models [2, 3]. However, the gut is
potentially more exposed to oxidant injury due to the
low concentration of antioxidant enzymes (superoxide
dismutase, catalase, glutathione peroxidase), which are
mainly localized in epithelial cells [4].
Two cytoplasmic enzymes, superoxide dismutase
(SOD) and myeloperoxidase (MPO), protect the cell con-
tents against oxidizing activity by destroying superoxide
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anions(−O2)andhydrogenperoxide(H2O2),respectively
[5]. Also MPO is one of the indicators of inﬂammation
anditiswellcorrelatedwithneutrophilinﬁltrationinvar-
ious colitis models. SOD reduces the oxidative stress and
the activation of mediators of inﬂammatory response [6].
Severe oxidative stress produces ROS and induces un-
controlled lipid peroxidation. The oxidation of polyun-
saturated fatty acids is accompanied by the formation of a
complex mixture of products including aldehydes,such as
alkanals, alk-2-enals, alka-2,4-dienals, and malondialde-
hyde (MDA) [7, 8]. MDA is frequently used in the mea-
surement of lipid peroxide levels. Elevated levels of MDA
are shown in IBD also.
Some agents have already proved eﬀective in experi-
mental conditions, and clinically the antioxidants as su-
peroxide dismutase and allopurinol were found to be of
beneﬁt in IBD. The eﬃcacy of current standard therapy,
for example, aminosalicylates, was found to be related to
their antioxidant and scavenging action [9]. Compounds
with antioxidant activity should therefore be investigated
as potential therapeutic agents in IBD. We chose N-
acetylcysteine (NAC) and L-carnitine (LCAR) as antiox-
idant agents.
The aim of the present study was to evaluate the ef-
f e c t so fN A Ca n dL C A Rs u p p l e m e n t a t i o n so np o l y m o r -
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plasma MDA in acetic acid (AA)-induced ulcerative coli-
tis.
MATERIALS AND METHODS
Fourty male Wistar-albino rats weighing 210–240g
were used. The animals were housed under 12-hour
light/darkcyclesataconstanttemperature(21–22◦C)and
fed on a standard rat chow and water ad libitum. The rats
were randomly divided into four groups: Group I, control
group (n = 10); Group II, colitis group (n = 10); Group
III, colitis pretreated with NAC (n = 10); and Group IV,
colitis pretreated with LCAR (n = 10).
Inductionofcolitisandtreatmentprotocols
Colitis was induced by intracolonic instillation of
1mL of 4%AA. After ether anesthesia a soft 6F pediatric
catheter was inserted into the lumen of the colon via the
anus for 6cm and AA was carefully administered. Control
ratsweretreatedidenticallybutinsteadof4%AA,theyre-
ceived 1mL 0.9% saline infusion.
NACandLCARwereperformedintraperitoneallyone
hour before the induction of colitis in Groups III and
IV, respectively. Both agents were applied as 500mg/kg in
one milliliter. Blood samples were obtained for biochem-
ical tests prior to sacriﬁcation of the rats at 24 hour fol-
lowing the treatment. Under general anesthesia, all rats
were sacriﬁced by cervical dislocation and then laparo-
tomy was performed. The distal 8cm of the colon was
excised, freed of adherent adipose tissue, and opened lon-
gitudinally. The colon was immediately examined visually
and observed for the damage.
Biochemicalanalysis
Isolationofpolymorphonuclear(PMN)leukocytes
Blood was drawn from heart of rat with a heparinized
disposable syringe, and mixed with 6% dextran in saline
in a ratio of 4 : 1 and allowed to stand for 60 minutes
at room temperature. The supernatant was removed and
centrifuged at 275g for 10 minutes. The resulting cell pel-
let was resuspended in 8mL of 0.1M phosphate buﬀer
(pH7.4),layeredover3mLofFicoll-Hypaqueandspunat
450g for 30 minutes at 4◦C. The cell pellet that contained
the PMN was then resuspended in phosphate buﬀer and
3mL of erythrocyte lysing solution (0.87% NH4Cl) was
added. The cell suspension was centrifuged at 275g for
5 minutes, the supernatant was discarded, the pellet was
washedthreetimeswithHank’sbalancedsolution(HBSS)
and resuspended in 1mL of HBSS. Cell numbers in the
ﬁnal suspension were counted and the suspension was
stored at −20◦C.
PreparationofPMNhomogenates
The PMN suspension was frozen at −20◦Ca n d
thawedsix times, thenhomogenized using a motordriven
Teﬂon-glass homogenizer (9000rpm for 5min at 0◦C).
The protein content of the homogenate was measured us-
ing Lowry’s method [10].
MeasurementofMPOactivity
MPO activity was determined by a modiﬁcation of
the O-dianisidine method [11]. The assay mixture, in
a cuvette of 1cm path length, contained 0.3mL 0.1M
phosphate buﬀer (pH 6.0), 0.3mL 0.01M H2O2,0 . 5m L
0.02M O-dianisidine (freshly prepared) in deionized wa-
ter and 10µLPMNhomogenateinaﬁnalvolumeof3mL.
ThePMNhomogenatewasaddedatlastandthechangein
absorbance at 460nm was followed for 10min. All mea-
surementswerecarriedoutinduplicate.OneunitofMPO
isdeﬁnedasthatgivinganincreaseinabsorbanceof0.001
per min and speciﬁc activity is given as IU/mg protein.
MeasurementofCu/Zn-SODactivity
Cu/Zn-SOD activity was measured according to the
method described by Fridovich [12]. This method em-
ploys xanthine and xanthine oxidase to generate superox-
ide radicals that react with p-iodonitrotetrazolium violet
(INT) to form a red formazan dye that was measured at
505nm. Assay medium consisted of the 0.01M phosphate
buﬀer, 3-cyclohexilamino-1-propanesulfonicacid (CAPS)
buﬀer solution (50mM CAPS, 0.94mM EDTA, saturated
NaOH)withpH10.2,PMNhomogenate,solutionofsub-
strate (0.05mM xanthine, 0.025mM INT) and 80IU/L
xanthine oxidase. Cu/Zn-SOD activity was expressed as
IU/mg protein.
MeasurementofMDAlevels
Lipid peroxidation level in the plasma samples was
expressed in MDA. It was measured according to proce-
dureofOhkawaetal[13].Thereactionmixturecontained
0.1mL sample, 0.2mL of 8.1% sodium dodecyl sulphate
(SDS), 1.5mL of 20% acetic acid, and 1.5mL of 0.8%
aqueous solution of TBA. The mixture pH was adjusted
to 3.5 and volume was ﬁnally made up to 4.0mL with
distilled water and 5.0mL of the mixture of n-butanol
and pyridine (15 : 1,v/v) were added. The mixture was
shaken vigorously. After centrifugation at 4000rpm for
10min, the absorbance of the organic layer was measured
at 532nm. Plasma MDA level was expressed as nmol/mL.
Measurementofproteinlevels
The protein concentration of the urine samples was
measured by Spectronic-UV 120 spectrophotometer by
the method of Lowry [10].
Statisticalanalysis
Statistical analysis was performed by using SPSS 9.0
version for Windows Operating System. The results were
analyzed using one-way ANOVA test. The signiﬁcance
level was set at P<. 05.392 Ergul Belge Kurutas et al 2005:6 (2005)
Table 1. The eﬀects of NAC and LCAR on PMN leukocyte MPO and Cu/Zn-SOD activity. Note: data are presented as mean ± SD;
PMN, polymorphonuclear; SOD, superoxide dismutase; MPO, myeloperoxidase; NAC, N-acetylcysteine; and LCAR, L-carnitine.
PMN leukocyte MPO
activity (IU/mg protein)
PMN leukocyte Cu/Zn-SOD
activity (IU/mg protein)
Control group (n = 10) 0.20 ±0.02∗ 0.28 ±0.02∗
Colitis group (n = 10) 0.68 ±0.02∗∗ 0.44 ±0.04∗∗
NAC pretreatment group (n = 10) 0.41 ±0.08 0.18 ±0.02
LCAR pretreatment group (n = 10) 0.38 ±0.06 0.33 ±0.03
∗P<. 05, signiﬁcantly diﬀerent from treatment groups.
∗∗P<. 001, signiﬁcantly diﬀerent from control and treatment groups.
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Figure 1. Plasma MDA (malondialdehyde) levels in AA-induced colitis in rats. Data are mean ± SD of 10 rats per group. #, colitis
group was signiﬁcantly diﬀerent from other groups (P<. 001); ∗, control group was signiﬁcantly diﬀerent from pretreatment groups
(P<. 001).
RESULTS
T h er a t st r e a t e dw i t ha c e t i ca c i dd e v e l o p e da c u t e
colitis at the incidence of 100%. During the study none
of the rats died or were excluded from the study for any
reason. The mean PMN leukocyte MPO and SOD activ-
ities were signiﬁcantly higher in the colitis group than in
the control group. Both NAC and LCAR pretreatment
signiﬁcantly decreased MPO and SOD activities com-
pared to colitis group (P<. 001) (Table 1). Furthermore,
when control and treatment groups were compared by
means of MPO and SOD activities, MPO activities were
found signiﬁcantly higher in treatment groups, while
SOD activity was found signiﬁcantly lower in LCAR
group compared to the control. SOD activity in the NAC
treatment group was also found markedly higher than the
control group (Table 1). AA administration signiﬁcantly
increased the levels of plasma MDA in comparison with
controls. However, NAC and LCAR administration to
the AA-treated rats signiﬁcantly reduced the MDA levels
compared to colitis group (P<. 001). When treatment
groups and the control were compared, MDA levels were
found signiﬁcantly higher in NAC and LCAR groups than
in the control group (Figure 1).
DISCUSSION
Many factors have been implicated in the pathogene-
sis of UC, such as neutrophil inﬁltration and overproduc-
tion of proinﬂammatory mediators including cytokines,
arachidonate metabolites, and ROS [14, 15]. The tissue
injury produced by neutrophils and macrophages has
been attributed to their ability to release ROS, nitrogen
metabolites, cytotoxic proteins, lytic enzymes, and cy-
tokines as well as their disrupting eﬀects on epithelial
integrity [16, 17]. Since abnormal oxidative metabolism
is of central importance in active UC, increased atten-
tion has been focused on the role of free radicals in UC
[18,19].IncreasedproductionofROSfromstimulatedin-
ﬂammatory cells as well as lipid peroxidation by-products
has been demonstrated in colorectal biopsy specimens of
patients with UC [18, 19, 20].
The protective eﬀects of various antioxidant agents
such as vitamin E and selenium [21], Zolimid and
AEOL11201[22],sodiumferulate[23],andtrimetazidine
[24,25]againsttheoxidativeinjuryinexperimentalcolitis
models were investigated. Additionally, ameliorating ef-
fectsoftopicaluseofpropionyl-LCARonthehistopathol-
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diﬀerent studies [26, 27]. We also showed the beneﬁcial
eﬀectsofNAC againstthehistopathologic and oxidant in-
jury in experimental colitis induced by acetic acid in a re-
cent article [28].
MPO, an enzyme found predominantly in activated
PMN leukocytes, is commonly used to quantify acute
colonic inﬂammation [29]. On the other hand, the corre-
lation between MPO activities and the histological anal-
ysis of neutrophil inﬁltration of the colon was reported
[30]. Colonic tissue MPO activities were shown to in-
crease and following the application of various anti-
inﬂammatory and antioxidant agents, tissue MPO levels
were demonstrated to decrease in the recent experimen-
tal colitis studies [31, 32, 33, 34]. However, there is not
enough data about the level of MPO-derived circulating
PMN leukocytes in ulcerative colitis. In our study, the
mean MPO activity was signiﬁcantly higher in the colitis
group than in the control group. NAC and LCAR admin-
istration to the AA-treated rats signiﬁcantly reduced the
MPO activity compared to colitis group.
Lipid peroxidation augments tissue damage in ulcera-
tive colitis models. Girgin et al showed that MDA levels of
the colon increased in the chronic colitis rat model [24].
Various antioxidant and antiinﬂammatory agents used in
the treatment of the ulcerative colitis were shown to de-
c r e a s eM D Al e v e l s[ 35, 36, 37, 38]. On the other hand,
while it has been shown that colonic MDA levels are in-
creased both in human and experimental studies, plasma
MDA changes are not understood enough. However, we
determined in this study that plasma MDA levels were in-
creased in colitis group and NAC and LCAR decreased the
levels of MDA.
SOD is an important protective system that acceler-
ates the dismutation of superoxide anion radicals to hy-
d r o g e np e r o x i d ea n da c t sa sap r i m a r yd e f e n s e ,a si tp r e -
vents further generation of free radicals. Results of the
studies examining the status of the antioxidant enzyme
SOD in experimental colitis are controversial. Kuralay et
al showed that tissue SOD levels were elevated in response
tooxidativestressinexperimentalcolitismodel,theywere
decreased by antioxidant agents [25]. However, angelica
sinensis and sodium ferulate have been demonstrated to
restore reduced colonic SOD levels in experimental coli-
tis [23, 33]. Kruidenier and colleagues demonstrated that
colonic mucosa Cu/Zn-SOD and Mn-SOD levels were
higher than the control levels in patients with inﬂamma-
tory bowel disease [39]. On the other hand, Verspaget
et al demonstrated lower activity of SOD in peripheral
blood neutrophils in ulcerative colitis patients [40]. Our
studyfoundthatneutrophil-relatedCu/Zn-SODlevelsin-
creased in colitis group and decreased after antioxidant
therapy. This increase in colitis group may be explained
by the response against oxidative stress.
OurﬁndingsindicatethattheNACandLCARsupple-
mentation to the rats with AA-induced colitis can signif-
icantly attenuate the increase in PMN leukocytes Cu/Zn-
SOD and MPO levels and plasma MDA levels; thus NAC
and LCAR protect the organism from AA-induced lipid
peroxidation. In conclusion NAC and LCAR could be
beneﬁcialagentsinrestoringcirculatingproinﬂammatory
mediators.
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